Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.

Autor(es): Juurlink David N.; Stukel Therese A.; Kwong Jeffrey.; Kopp Alexander.; McGeer Allison.; Upshur Ross E.; Manuel Douglas G.; Moineddin Rahim; Wilson Kumanan

Resumo: Whether influenza vaccination is associated with Guillain-Barré syndrome (GBS) remains uncertain. We conducted 2 studies using population-based health care data from the province of Ontario, Canada. In the first study, we used the self-matched case-series method to explore the temporal association between probable influenza vaccination (adults vaccinated during October and November) and subsequent hospitalization because of GBS. In the second study, we used time-series analysis to determine whether the institution of a universal influenza immunization program in October 2000 was associated with a subsequent increase in hospital admissions because of GBS at the population level. From April 1, 1992, to March 31, 2004, we identified 1601 incident hospital admissions because of GBS in Ontario. In 269 patients, GBS was diagnosed within 43 weeks of vaccination against influenza. The estimated relative incidence of GBS during the primary risk interval (weeks 2 through 7) compared with the control interval (weeks 20 through 43) was 1.45 (95% confidence interval, 1.05-1.99; P = .02). This association persisted in several sensitivity analyses using risk and control intervals of different durations. However, a separate time-series analysis demonstrated no evidence of seasonality and revealed no statistically significant increase in hospital admissions because of GBS after the introduction of the universal influenza immunization program. Influenza vaccination is associated with a small but significantly increased risk for hospitalization because of GBS.

Imprenta: Archives of Internal Medicine, v. 166, n. 20, p. 2217-2221, 2006

Identificador do objeto digital: 10.1001/archinte.166.20.2217

Descritores: Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Vaccine ; Guillain-Barre Syndrome - Epidemiology ; Guillain-Barre Syndrome - Public health

Data de publicação: 2006